N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-2-(phenylamino)benzamide

ID: ALA4740522

PubChem CID: 141755657

Max Phase: Preclinical

Molecular Formula: C24H23N3O2

Molecular Weight: 385.47

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  COc1ccc2[nH]cc(CCNC(=O)c3ccccc3Nc3ccccc3)c2c1

Standard InChI:  InChI=1S/C24H23N3O2/c1-29-19-11-12-22-21(15-19)17(16-26-22)13-14-25-24(28)20-9-5-6-10-23(20)27-18-7-3-2-4-8-18/h2-12,15-16,26-27H,13-14H2,1H3,(H,25,28)

Standard InChI Key:  MALXHVGKGSHLTJ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 29 32  0  0  0  0  0  0  0  0999 V2000
    3.5898   -3.2579    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5886   -4.0851    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3033   -4.4979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3015   -2.8451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0168   -3.2542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0216   -4.0805    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8090   -4.3313    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2908   -3.6599    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8012   -2.9943    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0514   -2.2083    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8572   -2.0320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4128   -2.6418    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2186   -2.4656    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7742   -3.0754    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.4689   -1.6797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.5207   -3.8606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0755   -4.4701    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8823   -4.2940    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.1313   -3.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5749   -2.8972    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7145   -4.0351    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4626   -4.8205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6548   -4.9914    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4028   -5.7760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9573   -6.3879    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7670   -6.2100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0154   -5.4256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8752   -2.8455    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1609   -3.2582    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  6  2  0
  5  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  8  9  2  0
  9  5  1  0
  9 10  1  0
 10 11  1  0
 11 12  1  0
 12 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 14  1  0
 16 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  1 28  1  0
 28 29  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4740522

    ---

Associated Targets(Human)

PTGS1 Tclin Cyclooxygenase-1 (9233 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MGC-803 (6426 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SGC-7901 (2773 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HGC-27 (1452 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
AGS (1999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

C6 (2371 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BV-2 (3710 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 385.47Molecular Weight (Monoisotopic): 385.1790AlogP: 4.89#Rotatable Bonds: 7
Polar Surface Area: 66.15Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 5.74CX LogD: 5.74
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.42Np Likeness Score: -0.94

References

1. Fan X,Li J,Deng X,Lu Y,Feng Y,Ma S,Wen H,Zhao Q,Tan W,Shi T,Wang Z.  (2020)  Design, synthesis and bioactivity study of N-salicyloyl tryptamine derivatives as multifunctional agents for the treatment of neuroinflammation.,  193  [PMID:32182488] [10.1016/j.ejmech.2020.112217]
2. Ma S, Zhu L, Fan X, Luo T, Liu D, Liang Z, Hu X, Shi T, Tan W, Wang Z..  (2021)  Melatonin derivatives combat with inflammation-related cancer by targeting the Main Culprit STAT3.,  211  [PMID:33248852] [10.1016/j.ejmech.2020.113027]

Source